“Orthogonal Thinker
Our mission is to give people access to nature’s most effective health solutions while setting the standard of a new “Farma”, Food as Medicine.
Contact us
What does wellness mean?
We live in a toxic environment
84M
American adults are prediabetic
90%
Americans consume unhealthy levels of sodium
40M
American adults suffer from some form of anxiety
300M
suffer from depression worldwide
240M
addicted to alcohol
1M
use tabacco
15M
reliant on opiods or heroin
Orthogonal’s Solution
We are a multidimensional wellness platform.
Our platform approach allows shareholders to benefit from the revenues of multiple holdings and subsidiaries.
We envision a future where “farmaceutical” products will usher in a new period of health and wellness based on psychoactive compounds and clean label products
New Compounds | Food as Medicine | Transparency
Our Core Assets
EI.Ventures
EI Ventures centers around the research and development of FDA-approved psychoactive compounds and nutritional alkaloids to deliver customized compounds and personalized formulas.
Learn more
Maui Raw
Maui Raw is our non-GMO, raw-foods brand, consisting of over 60 proprietary product formulations and over 10 CPG products.
Learn more
Alkaloid Accelerator
Through our Alkaloid Accelerator, we invest in and collaborate with companies and entrepreneurs that share our corporate values and priorities.
Learn more
Our Team
David Nikzad
Founder & Chairman
Jason A. Hobson
Co-founder & CEO
Michelle Valentin
Chief Food Formulator & Founder of Maui Raw
Learn more
Alexander Speiser
Chief Operating Officer
Nate Sumbot
General Counsel
Our Advisors
Grant Trahant
|Digital Media
Brian Johnson
|Strategic Advisor
Linda Straus
|Clinical Advisor
Christian Sullivan
|Strategic Advisor
Allen Grant
|Strategic Advisor
Emily Culpa
|Clinical Advisor
David Hua
|Strategic Advisor
Travis Wilson
|Outside Council
Jack Rentz, MD
|Strategic Advisor
Jeff Pasquerella
|Compliance
Aram Ordubegian
|Outside Council
Kevin Matthews
|Strategic Advisor
Subscribe
Sign up for news and updates.
Email Address
We respect your privacy.
Orthogonal Thinker
Our platform approach allows shareholders to benefit from the revenues of multiple holdings and subsidiaries. We envision a future where “farmaceutical” products will usher in a new period of health and wellness based on psychoactive compounds and clean label products.
Contact Us
1215 S. Kihei Rd.
Kihei, HI 96753
© 2020 Orthogonal Thinker. All rights reserved.
Risk Disclaimers: Any financial investment involves risk. You should not invest any funds in Orthogonal Thinker unless you can afford to lose your entire investment. In making an investment decision, investors must rely on their own examination of the merits and risks involved. An investment in Orthogonal Thinker or its Securities has not been recommended or approved by any federal or state securities commission or regulatory authority. Furthermore, these authorities have not passed upon the accuracy or adequacy of this report.
The U.S. Securities and Exchange Commission does not pass upon the merits of any securities offered or the terms of the offering, nor does it pass upon the accuracy or completeness of any offering document or literature or investment report. The securities may be illiquid and may not have a secondary market. In addition, the Company may never undergo a liquidity event such as a sale of the Company or an IPO or an STO. The Securities are not equity interests, have no ownership rights, have no rights to the Company’s assets or profits and have no voting rights or ability to direct the Company or its actions. The Securities have numerous transfer restrictions and will likely be highly illiquid, with no secondary market on which to sell them. Purchasers could hold Securities for many years without income generation. The majority of investments would involve long term prospects not short term gains.”
Learn more at https://www.orthogonalthinker.com/
